AstraZeneca Pharma India has informed that the Meeting of the Board of Directors of the company will be held on Friday, November 7, 2025 to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2025. The company has informed that the ‘Trading Window’ remains closed for all Designated Persons, from September 16, 2025 to November 9, 2025 in terms of the company - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
The above information is a part of company’s filings submitted to BSE.
